Urinary Tract Infection Treatment Market
According to Intent Market Research, the Urinary Tract Infection Treatment Market is expected to grow from USD 7.5 Billion in 2024-e at a CAGR of 7.8% to touch USD 11.8 Billion by 2030. The Urinary Tract Infection Treatment Market is dominated by key players such as Pfizer Inc., GlaxoSmithKline plc, Johnson & Johnson (Janssen Pharmaceuticals), Sanofi S.A., AbbVie Inc., and Mylan N.V. (Pfizer subsidiary).